Investors looking for international diversification often turn to one of two established developed-market ETFs: the iShares MSCI EAFE ETF (EFA) and the Vanguard FTSE Developed Markets ETF (VEA). Both target developed equity markets outside the United States, so they serve a similar role in many portfolios. Still, differences in country coverage, index construction, number of holdings, and costs matter. From what I see, understanding those details helps determine which one aligns better with an investor’s objectives, especially when an AI-driven approach is applied to the current environment.
EFA seeks to track the MSCI EAFE Index, a free-float-adjusted, market-capitalization-weighted measure of large- and mid-cap developed-market equities in Europe, Australasia, and the Far East. The index leaves out the United States and Canada, and because MSCI views South Korea as emerging, the fund has no exposure there. It uses optimized sampling to hold roughly 700 to 900 securities and carries an expense ratio of 0.32%. Top holdings center on European multinationals such as ASML, Roche, Shell, HSBC, Novartis, Nestlé, AstraZeneca, SAP, Mitsubishi UFJ Financial Group, and Siemens. Sector weights lean toward financials (about 24–26%), industrials (roughly 18–19%), information technology (around 10–11%), and healthcare (near 10%). Japan, the United Kingdom, France, Germany, Switzerland, and Australia form the main geographic anchors. I also checked this using Tickeron’s AI Screener to see how the fund compares with peers.
VEA follows the FTSE Developed All Cap ex US Index, which covers large-, mid-, and small-cap stocks across developed markets outside the United States. This benchmark includes Canada and South Korea and extends into small caps. The fund uses full replication and holds nearly 4,000 stocks, with its ten largest positions making up only about 10% of assets. Its expense ratio stands at just 0.03%. Because FTSE classifies South Korea as developed, top holdings feature Samsung Electronics and SK Hynix alongside ASML, HSBC, Novartis, Royal Bank of Canada, Roche, AstraZeneca, Nestlé, and Siemens. Sector exposure remains similar—financials near 24%, industrials about 19%, and technology around 11%—while country weights are led by Japan, the United Kingdom, and Canada, with the latter contributing roughly 11% of assets.
Both ETFs operate in the international large-blend category and respond to the same macro drivers: central-bank rate decisions, currency fluctuations, European industrial trends, and the global semiconductor cycle. Artificial intelligence has become a notable theme, directing attention to semiconductor and chip-equipment suppliers in Europe and Asia. This dynamic favors funds with solid technology exposure. Developed-market equities continue to trade at a valuation discount to U.S. large caps, which can support periodic rotation into international benchmarks. Risks include currency swings, euro-area and Japanese economic softness, energy price changes, and geopolitical tensions affecting exporters.
In recent periods the two ETFs have largely moved together, consistent with their shared mandate and overlapping holdings. Relative positioning has differed on two main points. VEA’s inclusion of South Korean memory-chip makers Samsung Electronics and SK Hynix has provided greater exposure to the AI and semiconductor cycle. Its Canadian allocation also adds stability through large financials and commodity-linked names that EFA does not hold. EFA has tended to deliver a modestly higher dividend yield and a purer large- and mid-cap focus. On a volatility-adjusted basis, VEA’s broader diversification and lower cost have supported slightly more consistent positioning across market regimes.
When analyzing ETFs like these, I often turn to Tickeron’s AI Screener to filter securities by technical patterns, fundamentals, and AI-driven signals. The tool lets users scan thousands of names with customizable criteria such as industry, market cap, and performance metrics, helping surface relevant ideas more efficiently than manual review. In my view, running EFA and VEA through this process highlights how their structural differences play out in real time.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
EFA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 34 of 41 cases where EFA's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 83%.
The Moving Average Convergence Divergence (MACD) for EFA just turned positive on October 15, 2026. Looking at past instances where EFA's MACD turned positive, the stock continued to rise in 34 of 44 cases over the following month. The odds of a continued upward trend are 77%.
Following a +0.73% 3-day Advance, the price is estimated to grow further. Considering data from situations where EFA advanced for three days, in 260 of 314 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 46 of 60 cases where EFA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 77%.
The Momentum Indicator moved below the 0 level on November 03, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on EFA as a result. In 66 of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 81%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EFA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.
The Aroon Indicator for EFA entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category ForeignLargeBlend